Juxtapid Maker Gets FDA Warning Letter Over Misleading Statements
The makers of Juxtapid received an FDA warning letter after television appearances the agency says included misleading statements about the drug.
November 12, 2013 By: Martha Garcia
The makers of Juxtapid received an FDA warning letter after television appearances the agency says included misleading statements about the drug.
The FDA is requiring new label warnings to alert patients and doctors to the risk of Ozempic intestinal blockage side effects.
Eight women have filed Uber sexual assault lawsuits, claiming the rideshare service failed to protect them from predatory drivers due to its lack of safety measures.
A new report highlights how many women and families feel left out of Camp Lejeune settlement negotiations after suffering repeated miscarriages they say were caused by miscarriages on the North Carolina military base.